top of page

Search


invitrace at ICHOM 2025: Driving Measurable Impact in Value-Based Healthcare
From 29 September to 1 October 2025 , Invitrace participated in ICHOM 2025 (International Consortium for Health Outcomes Measurement) in Dublin, Ireland , engaging with global healthcare leaders to advance the principles of Value-Based Healthcare (VBHC) — a model that places patient-reported outcomes at the center of meaningful, high-value care. During the conference, Mr. Supanudh Vitheethum , Lead Global Business Development (UK) of Invitrace, and Dr. Chantas Mahaisavari


invitrace Welcomes Global Partners from Brazil to Accelerate Healthcare Performance
On August 5th, invitrace had the honor of welcoming global partners — Mr. Shohei Koide , President of Toyota Tsusho Medical Welfare Management (Thailand) Co., Ltd.; Mr. Tomohiko Sakai, President of Toyota Tsusho Corretora De Seguros Ltda; and Dr. Claudio José Albuquerque e Silva, Chief Medical Officer of MDS Brazil. The visit served as a meaningful professional exchange, focused on shared insights and perspectives on how strategic collaboration and innovative approaches ca


invitrace Signs MOU with TLWA to Transform Preventive Healthcare with Measurable Impact
invitrace has entered a memorandum of understanding with the Thai Lifestyle Medicine and Wellbeing Association (TLWA) to strengthen preventive health initiatives in Thailand. The partnership combines TLWA’s academic expertise with invitrace’s capabilities in health data and AI, enabling practical, accessible, and impactful preventive care for the Thai population. Together, both organizations will advance research in lifestyle medicine, share actionable insights with healthca


Invitrace Co., Ltd. developed a Telemedicine system for Phyathai-Paolo Hospital Group
Invitrace Co., Ltd. developed a Telemedicine system for Phyathai-Paolo Hospital Group in response to the hospital's digital...
bottom of page